Is CHA₂DS₂-VASc appropriate for hyperthyroid patients with atrial fibrillation? Implications of adding a transesophageal echocardiography evaluation

详细信息    查看全文

• 作者：Marcus Vinicius Leitã ; o de Souza^a ; ^{marcusleitao@hucff.ufrj.br} ; Patricia de Fá ; tima dos Santos Teixeira^a ; Mario Vaisman^a ; Sergio Salles Xavier^b
• 关键词：Hyperthyroidism ; Atrial fibrillation ; Transesophageal echocardiography ; CHA2DS2-VASc ; Thrombogenic milieu ; Pulmonary hypertension
• 刊名：International Journal of Cardiology
• 出版年：2017
• 出版时间：1 February 2017
• 年：2017
• 卷：228
• 期：Complete
• 页码：919-925
• 全文大小：360 K
• 卷排序：228

文摘

Embolic risk in atrial fibrillation (AF) related to hyperthyroidism is controversial Transesophageal echocardiography (TEE) abnormalities can predict an embolic event CHA2DS2-VASc is the main clinical tool to guide antithrombotic therapy CHA2DS2-VASc score is highly related to transesophageal echocardiography findings No association between TEE and CHA2DS2-VASc in AF related to hyperthyroidism